Bioequivalence Study of Sotalol, Tablets, 160 mg (Pharmtechnology LLC, Belarus), and Sotalex ®, Tablets, 160 mg (Bristol-Myers Squibb GmbH & Co. KGaA, Germany), in Healthy Volunteers Under Fasting Conditions
Clinical trial NCT03799536 · COMPLETED
Trial details
- NCT number
- NCT03799536
- Sponsor
- Pharmtechnology LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-09
- Primary completion
- 2019-02-04
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.